genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Search
  • About GEN
  • Contact GEN
  • Subscribe/Update Preferences
  • Log In
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Autoimmune Disease Drugs

      Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

      Novel Coronavirus (2019-nCoV) Corona virus vaccine vial dose flu shot drug needle syringe medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization
      Antibodies

      Monoclonal Antibody Prevents Malaria in Clinical Trial

      Alzheimers

      Novel Alzheimer’s Therapy without Inflammatory Side Effects

      News

      Muscle Regeneration May Be Boosted by Naturally Occurring Compound

      Bacteriophages infecting bacteria, illustration
      Bacteriophage

      Oral Combination Phage Therapy Targets IBD-Related Gut Bacteria, Spares Helpful Microbes

  • Insights
    • AllTrends for 2020Trends for 2021
      Amyloid plaques in Alzheimer's disease
      Alzheimers

      Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

      Cancer

      Left-Field Lessons in Immunity: Z-Nucleic Acids Stage a Comeback

      Woman with lab coat in technical room with a fermenter
      Antibodies

      Biomanufacturing Parallels the Semiconductor Chip Revolution

      Two scientists in conversation, standing in laboratory
      Bioprocessing

      Altering Vector Genetics Improves Cell-free Protein Synthesis

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

      coronavirus
      A-Lists

      Seven Biopharma Trends to Watch in 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Home Liver Diseases

Liver Diseases

  • 10x Genomics
  • A-Lists
  • AgBio
  • Age-Related Disorders
  • Aging
  • AGTC
  • alcohol
  • Alexandria Real Estate Equities
  • Allergic Diseases
  • Application Notes
  • Artificial Intelligence
  • Autoimmune Disorders
  • Bacterial Diseases
  • Bacteriophage
  • Base Editing
  • Bayer
  • BeiGene
  • Biodefense/Bioterrorism
  • Bioethics
  • Biomarker Discovery
  • BioNTech
  • BioPerspectives
  • Blockchain
  • Blood Disorders
  • Boehringer Ingelheim
  • Bone disorders
  • Brexit
  • Bristol-Myers Squibb
  • canine
  • Cardiovascular Disease
  • Careers
  • Celgene
  • Cell Analysis
  • Cell Biology
  • Cell Culture
  • Cell Line Development
  • Cell Signaling
  • Cell Therapy
  • Cellular Analysis
  • China
  • Chromatography
  • Circadian Rhythm
  • Commentary
  • Compound Synthesis
  • Computational Biology
  • Computer Simulation
  • COVID-19 Candidates
  • CRISPR
  • CRISPR/Cas9
  • Danaher
  • Developmental Disorders
  • DNA Repair
  • Drug Resistance
  • Ear Disorders
  • Economic development
  • Education and training
  • eGenesis
  • Electrophoresis
  • Eli Lilly
  • Employment Trends
  • Endocrine Disorders
  • Evolution
  • Extracellular Matrix
  • Eye Disorders
  • Fill and Finish
  • Financing
  • Five Prime Therapeutics
  • Flow Cytometry
  • Forensics
  • Fungal Diseases
  • Gastrointestinal Disorders
  • GEN 40
  • GEN Edge
  • Genentech
  • Genetic Disease Testing
  • Genetics
  • Glycan Analysis
  • Glycoproteins
  • GWAS
  • Hematologic Conditions
  • Histology
  • HPLC
  • Hypertension
  • Imaging
  • Immunoassay
  • Immunochemistry
  • Immunology
  • In-vitro Fertilization
  • Industry News
  • Inflammatory Diseases
  • Information Management
  • Insights
  • interleukin
  • Ion Channels
  • Ireland
  • Kidney Diseases
  • Kinases
  • Literature Review
    7 days popular
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Liver Diseases

    FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test

    Liver Diseases

    EHSI Forms JV to Evaluate a Regenerative Medicine Method

    Liver Diseases

    Dainippon Sumitomo Pays Intercept $15M for Phase III Liver Disease Drug

    Liver Diseases

    Gilead to Acquire Phenex’s FXR Program for Up-to-$470M

    Stop Sign On Hand
    Liver Diseases

    AstraZeneca Halts Development of Regulus NASH Candidate

    Recently Featured

    Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

    Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

    Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

    Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

    Novel Alzheimer’s Therapy without Inflammatory Side Effects

    Novel Alzheimer’s Therapy without Inflammatory Side Effects

    Muscle Regeneration May Be Boosted by Naturally Occurring Compound

    Muscle Regeneration May Be Boosted by Naturally Occurring Compound

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Protocols
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Inside Precision Medicine
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up